Sermorelin is a peptide analog of growth hormone-releasing hormone, not an anabolic steroid. It acts through the growth hormone-releasing pathway. Anabolic steroids are related to testosterone and belong to a different drug family.

That distinction answers the classification question, but it does not establish that sermorelin is harmless, approved for bodybuilding, or allowed in tested sport. Drug identity, medical suitability, product approval, and sporting rules are separate questions that deserve separate answers.

The considered take

Sermorelin is a peptide, not an anabolic steroid. That does not make it a supplement or remove prescription and sporting restrictions.

The pathway differs from testosterone treatment

Testosterone acts through androgen-related pathways. Sermorelin signals growth hormone release through a different receptor system. Calling both hormone-related treatments does not make them substitutes, and it does not establish that either is appropriate for a person with fatigue or a training goal.

If low testosterone is the concern, diagnosis requires an appropriate clinical evaluation rather than choosing a peptide because it sounds less intimidating. Our testosterone and TRT guide explains why treatment decisions for one hormone pathway cannot simply be transferred to another.

Sources: DEA: Steroids drug fact sheet · Sigalos and Pastuszak: Safety and efficacy of growth hormone secretagogues · Endocrine Society: Testosterone therapy guideline

Sermorelin is also different from injected growth hormone

Sermorelin stimulates a signaling pathway involved in the body's release of growth hormone. A growth hormone injection supplies the hormone itself. Those are different interventions, even when a commercial page groups them under the same wellness goal.

Neither distinction establishes a blanket safety ranking for every patient and preparation. Clinical evidence needs to identify the molecule, exposure, diagnosis, and measured outcome. Read sermorelin versus HGH and the clinical-studies guide before treating a mechanism diagram as proof of better results.

Sources: Mayo Clinic: Sermorelin injection information · Sigalos and Pastuszak: Safety and efficacy of growth hormone secretagogues · Endotext: Growth Hormone and Aging

A peptide can still be a regulated prescription medicine

The word peptide describes a type of molecule. It is not a promise that a product is gentle, a dietary supplement, or suitable for use without clinical oversight. Current compounded sermorelin preparations are not FDA-approved, even though historical GEREF products had an approval history.

Do not substitute a research-only powder for a pharmacy-dispensed prescription. Verify the clinician, pharmacy, and exact formulation, and request instructions specific to that product. Our FDA-approval article separates the historical product from what a patient may be offered today.

Sources: FDA: Compounding questions and answers · FDA: 2013 GEREF withdrawal determination · Mayo Clinic: Sermorelin injection information · NABP: Buy medication safely

Not being a steroid does not make it permitted in sport

The 2026 WADA Prohibited List names sermorelin within the growth hormone-releasing factors category and prohibits it at all times. That is separate from the anabolic-agent category. A prescription by itself does not resolve an athlete's anti-doping obligations.

Check the rules of the relevant organization and its therapeutic-use-exemption process before treatment if they apply to you. Do not rely on a “steroid-free” marketing claim as sporting clearance. The sports and drug-testing article explains the rule distinction without offering detection-avoidance advice.

Sources: WADA: 2026 Prohibited List

Sources behind this article

Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.

  1. DEA: Steroids drug fact sheetUS government drug information · Anabolic steroid classification; separate from peptide identity and sporting rules.
  2. Sigalos and Pastuszak: Safety and efficacy of growth hormone secretagoguesClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
  3. Endocrine Society: Testosterone therapy guidelineClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
  4. Mayo Clinic: Sermorelin injection informationClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
  5. Endotext: Growth Hormone and AgingExpert clinical evidence review · Separates hormone and body-composition findings from functional outcomes and long-term unknowns.
  6. FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
  7. FDA: 2013 GEREF withdrawal determinationFederal Register / FDA · Historical GEREF products were not withdrawn for safety or effectiveness reasons; this does not approve current compounds.
  8. NABP: Buy medication safelyPharmacy regulator association · Tools for checking online pharmacies and recognizing unsafe sellers.
  9. WADA: 2026 Prohibited ListPrimary or authoritative reference · Sermorelin named under S2.2.4; rules are sport- and year-specific.